4XCE

Crystal structure of human 4E10 Fab crystalized in the presence of Phosphatidylcholine (06:0 PC); C2 space group

Experimental procedure

Experimental method	SINGLE WAVELENGTH
Source type	SYNCHROTRON
Source details	SSRL BEAMLINE BL12-2
Synchrotron site	SSRL
Beamline	BL12-2
Temperature [K]	110
Detector technology	PIXEL
Collection date	2013-07-27
Detector	DECTRIS PILATUS 6M
Wavelength(s)	1.00000
Spacegroup name	C 1 2 1
Unit cell lengths	95.524, 164.309, 106.990
Unit cell angles	90.00, 106.68, 90.00

Refinement procedure

Resolution	46.995 - 2.930
R-factor	0.1946
Rwork	0.192
R-free	0.24730
Structure solution method	MOLECULAR REPLACEMENT
Starting model (for MR)	2fx7
RMSD bond length	0.004
RMSD bond angle	0.913
Data reduction software	HKL-2000 (HKL-2000 version 705b)
Data scaling software	HKL-2000 (HKL-2000 version 705b)
Phasing software	PHASER (2.5.2)
Refinement software	PHENIX ((phenix.refine: 1.8.4_1496))

Data quality characteristics

	Overall	Outer shell
Low resolution limit [Å]	46.995	2.980
High resolution limit [Å]	2.930	2.930
Rmerge		0.554
Number of reflections	31840
<I/σ(I)>	9	2.2
Completeness [%]	94.2	95.7
Redundancy	2.7	2.5

Crystallization Conditions

crystal ID	method	pH	temperature	details
1	VAPOR DIFFUSION	6.5	293	Sitting drops contain 4E10 Fab at 10 mg/ml, 10 mM Phosphatidylcholine (06:0 PC) sample mixed (1:1 v/v) with reservoir solution of 0.2 M potassium sodium tartrate, 20% PEG3350